SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Studholme Robert

(Last)

(First)

(Middle)

25651 ATLANTIC OCEAN DRIVE

(Street)

LAKE FOREST

92630

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
03/16/2022

3. Issuer Name and Ticker or Trading Symbol
STAAR SURGICAL CO [ STAA ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Senior VP,Operations

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	20,850⁽¹⁾	D
Common Stock	502	I	By spouse.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock Options	03/07/2023⁽²⁾	03/07/2032	Commmon Stock	12,547	$74.8	D
Common Stock Options	03/12/2022⁽³⁾	03/12/2031	Common Stock	4,879	$90.38	D
Common Stock Options	03/20/2021⁽⁴⁾	03/20/2030	Common Stock	14,629	$27.53	D
Common Stock Options	03/14/2022⁽⁵⁾	03/14/2029	Common Stock	24,284	$35.98	D
Common Stock Options	06/14/2021⁽⁵⁾	06/14/2028	Common Stock	2,368	$29.8	D
Common Stock Options	03/15/2021⁽⁵⁾	03/14/2028	Common Stock	10,015	$16.15	D
Common Stock Options	03/21/2020⁽⁵⁾	03/21/2027	Common Stock	10,000	$9.3	D
Common Stock Options	04/04/2019⁽⁵⁾	04/04/2026	Common Stock	10,000	$7.36	D

Explanation of Responses:

1. Of these, 9,917 are restricted shares subject to forfeiture rights, of which 2,010 will vest on 03/07/2023, 769 will vest on 03/12/2023, 2,346 will vest on 03/20/2023, 2,011 will vest on 03/07/2024, 770 will vest on 03/12/2024, and 2,011 will vest on 03/07/2025.

2. The options become exercisable as follows: 1/3 on 3/7/2023 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/7/2025.

3. The options become exercisable as follows: 1/3 on 3/12/2022 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/12/2024.

4. The options become exercisable as follows: 1/3 on 3/20/2021, and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/20/2023.

5. All options became exercisable on or before the stated date.

	/s/Samuel Gesten as Attorney-in-Fact for Robert Studholme	07/05/2022
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.